Optimum Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$399K Hold
4,750
0.16% 118
2025
Q2
$376K Sell
4,750
-50
-1% -$3.97K 0.16% 116
2025
Q1
$431K Sell
4,800
-350
-7% -$32.7K 0.2% 103
2024
Q4
$512K Sell
5,150
-250
-5% -$25.8K 0.23% 90
2024
Q3
$613K Sell
5,400
-1,000
-16% -$119K 0.27% 85
2024
Q2
$792K Hold
6,400
0.36% 62
2024
Q1
$844K Hold
6,400
0.39% 65
2023
Q4
$698K Sell
6,400
-800
-11% -$83K 0.35% 67
2023
Q3
$741K Sell
7,200
-150
-2% -$16.2K 0.38% 61
2023
Q2
$848K Buy
7,350
+800
+12% +$90.8K 0.42% 60
2023
Q1
$697K Sell
6,550
-272
-4% -$29.4K 0.37% 67
2022
Q4
$757K Buy
6,822
+300
+5% +$30.7K 0.41% 63
2022
Q3
$562K Sell
6,522
-55
-0.8% -$4.91K 0.3% 73
2022
Q2
$600K Sell
6,577
-39
-0.6% -$3.46K 0.3% 72
2022
Q1
$543K Sell
6,616
-104
-2% -$8.2K 0.23% 99
2021
Q4
$515K Sell
6,720
-550
-8% -$43.8K 0.2% 113
2021
Q3
$546K Sell
7,270
-1,786
-20% -$136K 0.23% 104
2021
Q2
$704K Sell
9,056
-2,547
-22% -$189K 0.22% 98
2021
Q1
$854K Sell
11,603
-786
-6% -$58K 0.25% 91
2020
Q4
$967K Sell
12,389
-367
-3% -$28.1K 0.29% 77
2020
Q3
$1.01M Sell
12,756
-845
-6% -$66.2K 0.34% 69
2020
Q2
$1M Sell
13,601
-183
-1% -$13.8K 0.35% 64
2020
Q1
$1.01M Sell
13,784
-679
-5% -$53.4K 0.41% 57
2019
Q4
$1.25M Sell
14,463
-42
-0.3% -$3.45K 0.37% 66
2019
Q3
$1.17M Sell
14,505
-278
-2% -$22.3K 0.37% 70
2019
Q2
$1.18M Sell
14,783
-49
-0.3% -$3.75K 0.38% 63
2019
Q1
$1.18M Buy
14,832
+584
+4% +$43.7K 0.39% 63
2018
Q4
$1.04M Sell
14,248
-262
-2% -$18.5K 0.36% 67
2018
Q3
$982K Sell
14,510
-970
-6% -$61.8K 0.27% 94
2018
Q2
$897K Buy
15,480
+75
+0.5% +$4.23K 0.26% 104
2018
Q1
$801K Sell
15,405
-1,028
-6% -$55.5K 0.24% 112
2017
Q4
$882K Buy
16,433
+184
+1% +$10.2K 0.28% 105
2017
Q3
$993K Buy
16,249
+576
+4% +$34.9K 0.33% 87
2017
Q2
$958K Buy
15,673
+1,168
+8% +$71.1K 0.33% 93
2017
Q1
$879K Buy
14,505
+524
+4% +$31.8K 0.31% 97
2016
Q4
$785K Sell
13,981
-62
-0.4% -$3.63K 0.3% 98
2016
Q3
$836K Sell
14,043
-446
-3% -$26.1K 0.31% 91
2016
Q2
$796K Sell
14,489
-1,572
-10% -$83.7K 0.31% 99
2016
Q1
$811K Buy
16,061
+4,048
+34% +$198K 0.32% 96
2015
Q4
$605K Sell
12,013
-1,286
-10% -$64.8K 0.23% 124
2015
Q3
$627K Buy
+13,299
New +$706K 0.25% 119
2015
Q1
$737K Sell
13,451
-13,664
-50% -$774K 0.23% 117
2014
Q4
$745K Buy
27,115
+12,685
+88% +$707K 0.24% 111
2014
Q3
$816K Buy
14,430
+641
+5% +$36K 0.27% 104
2014
Q2
$762K Buy
13,789
+365
+3% +$19.9K 0.25% 113
2014
Q1
$727K Buy
13,424
+1,625
+14% +$84.1K 0.27% 107
2013
Q4
$564K Sell
11,799
-3,862
-25% -$177K 0.21% 128
2013
Q3
$711K Buy
+15,661
New +$715K 0.29% 95

Other funds holding MRK

Optimum Investment Advisors's MRK Position: Q3 2025 in Review

Optimum Investment Advisors held its Merck (MRK) position steady in Q3 2025 at 4,750 shares worth $399K. The position accounts for 0.16% of the portfolio, ranked #118.

Optimum Investment Advisors first reported a position in MRK in Q3 2013 and has held it in 48 quarters since. The position peaked at $1.25M in Q4 2019. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Optimum Investment Advisors held 4,750 shares of Merck worth $399K as of Q3 2025.
  • Optimum Investment Advisors left its Merck share count unchanged in Q3 2025.
  • Merck made up 0.16% of Optimum Investment Advisors's portfolio in Q3 2025, its #118 holding.
  • Optimum Investment Advisors first reported a position in Merck in Q3 2013 and has held it in 48 quarters since.
  • Optimum Investment Advisors's Merck position peaked at $1.25M in Q4 2019.
  • 3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.